$521.88 Million in Sales Expected for LHC Group, Inc. (NASDAQ:LHCG) This Quarter
Analysts expect LHC Group, Inc. (NASDAQ:LHCG) to report $521.88 million in sales for the current fiscal quarter, according to Zacks Investment Research. Five analysts have issued estimates for LHC Group’s earnings, with the lowest sales estimate coming in at $511.07 million and the highest estimate coming in at $528.60 million. LHC Group reported sales of $502.02 million during the same quarter last year, which indicates a positive year over year growth rate of 4%. The firm is scheduled to announce its next earnings report after the market closes on Wednesday, August 7th.
According to Zacks, analysts expect that LHC Group will report full-year sales of $2.11 billion for the current fiscal year, with estimates ranging from $2.10 billion to $2.12 billion. For the next financial year, analysts anticipate that the firm will report sales of $2.23 billion, with estimates ranging from $2.20 billion to $2.26 billion. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that cover LHC Group.
LHC Group (NASDAQ:LHCG) last issued its quarterly earnings results on Wednesday, May 8th. The health services provider reported $0.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.08. LHC Group had a net margin of 3.83% and a return on equity of 8.43%. The business had revenue of $502.59 million for the quarter, compared to analyst estimates of $511.16 million.
In other news, COO Donald Dwayne Stelly sold 3,306 shares of the company’s stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $115.87, for a total transaction of $383,066.22. Following the transaction, the chief operating officer now owns 98,267 shares of the company’s stock, valued at approximately $11,386,197.29. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Ronald T. Nixon sold 12,000 shares of the company’s stock in a transaction on Wednesday, May 22nd. The shares were sold at an average price of $117.20, for a total value of $1,406,400.00. Following the transaction, the director now directly owns 29,100 shares in the company, valued at approximately $3,410,520. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 46,269 shares of company stock worth $5,314,613. 5.20% of the stock is owned by insiders.
Hedge funds and other institutional investors have recently made changes to their positions in the business. LPL Financial LLC boosted its holdings in LHC Group by 10.3% during the 4th quarter. LPL Financial LLC now owns 4,460 shares of the health services provider’s stock valued at $419,000 after acquiring an additional 417 shares during the period. Advisor Group Inc. increased its position in LHC Group by 10.3% during the 4th quarter. Advisor Group Inc. now owns 3,038 shares of the health services provider’s stock valued at $285,000 after buying an additional 284 shares in the last quarter. State of Tennessee Treasury Department increased its position in LHC Group by 6.0% during the 4th quarter. State of Tennessee Treasury Department now owns 18,477 shares of the health services provider’s stock valued at $1,735,000 after buying an additional 1,050 shares in the last quarter. Citigroup Inc. increased its holdings in shares of LHC Group by 265.2% in the 4th quarter. Citigroup Inc. now owns 4,386 shares of the health services provider’s stock worth $412,000 after purchasing an additional 3,185 shares in the last quarter. Finally, CIBC Asset Management Inc bought a new stake in shares of LHC Group in the 4th quarter worth $203,000. Institutional investors and hedge funds own 91.43% of the company’s stock.
Shares of LHC Group stock traded up $0.71 during trading hours on Friday, hitting $121.52. The company’s stock had a trading volume of 236,949 shares, compared to its average volume of 247,133. The firm has a fifty day moving average price of $117.95. The firm has a market cap of $3.87 billion, a P/E ratio of 34.23, a PEG ratio of 2.09 and a beta of 0.81. LHC Group has a 1-year low of $80.84 and a 1-year high of $128.31. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.21.
About LHC Group
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Featured Article: How to interpret a stock’s beta number
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.